Lipid Carrier

- the solubility people -

Situation analysis:

About 40% of drugs in the pipeline and 60% of drugs coming directly from synthesis or high throughput screening are classified as poorly soluble. Consequently, they have bioavailability and/or delivery problems.

The mission:

PharmaSol provides solutions for overcoming the solubility and related bioavailability problems of poorly soluble compounds. PharmaSol solutions are simple, cost-effective, regulatorily acceptable and cover lab to industrial scale production. Focus areas are oral, dermal and intravenous delivery.

PharmaSol's expertise:
Pharmaceutical solutions to increase the Solubility of poorly soluble compounds.

(C)opyright 2004, PharmaSol GmbH. All rights reserved.